ID: ALA4094921

Max Phase: Preclinical

Molecular Formula: C17H19N3O7

Molecular Weight: 377.35

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCOC(=O)C1=C(C)NC(=O)N(CCC(=O)O)C1c1cccc([N+](=O)[O-])c1

Standard InChI:  InChI=1S/C17H19N3O7/c1-3-27-16(23)14-10(2)18-17(24)19(8-7-13(21)22)15(14)11-5-4-6-12(9-11)20(25)26/h4-6,9,15H,3,7-8H2,1-2H3,(H,18,24)(H,21,22)

Standard InChI Key:  MGTYQRRJACHXHO-UHFFFAOYSA-N

Associated Targets(Human)

Voltage-gated T-type calcium channel alpha-1H subunit 1913 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Voltage-gated L-type calcium channel alpha-1C subunit 1321 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 377.35Molecular Weight (Monoisotopic): 377.1223AlogP: 1.97#Rotatable Bonds: 7
Polar Surface Area: 139.08Molecular Species: ACIDHBA: 6HBD: 2
#RO5 Violations: 0HBA (Lipinski): 10HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 3.62CX Basic pKa: CX LogP: 1.12CX LogD: -2.22
Aromatic Rings: 1Heavy Atoms: 27QED Weighted: 0.42Np Likeness Score: -1.13

References

1. Teleb M, Zhang FX, Farghaly AM, Aboul Wafa OM, Fronczek FR, Zamponi GW, Fahmy H..  (2017)  Synthesis of new N3-substituted dihydropyrimidine derivatives as L-/T- type calcium channel blockers.,  134  [PMID:28399450] [10.1016/j.ejmech.2017.03.080]

Source